Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04278222
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2020-02-19
Brief Title:
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 APICAL-GC
Sponsor:
Shanghai Changzheng Hospital
Organization:
Shanghai Changzheng Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-19
First Submit QC Date:
February 19 2020
Study First Post Date:
2020-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-09
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL